Steward Partners Investment Advisory’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-968
Closed -$5.65K 3460
2022
Q4
$5.65K Sell
968
-1,000
-51% -$5.84K ﹤0.01% 2734
2022
Q3
$13K Hold
1,968
﹤0.01% 2431
2022
Q2
$8K Hold
1,968
﹤0.01% 2614
2022
Q1
$7K Sell
1,968
-4,009
-67% -$14.3K ﹤0.01% 2803
2021
Q4
$19K Sell
5,977
-7,525
-56% -$23.9K ﹤0.01% 2356
2021
Q3
$44K Sell
13,502
-2,517
-16% -$8.2K ﹤0.01% 1973
2021
Q2
$68K Sell
16,019
-404,935
-96% -$1.72M ﹤0.01% 2772
2021
Q1
$2.1M Buy
420,954
+345,943
+461% +$1.73M 0.04% 419
2020
Q4
$948K Sell
75,011
-2,205
-3% -$27.9K 0.02% 578
2020
Q3
$758K Sell
77,216
-1,217
-2% -$11.9K 0.02% 563
2020
Q2
$780K Buy
78,433
+6,165
+9% +$61.3K 0.02% 519
2020
Q1
$638K Sell
72,268
-5,115
-7% -$45.2K 0.02% 504
2019
Q4
$713K Buy
77,383
+7,936
+11% +$73.1K 0.02% 536
2019
Q3
$408K Buy
69,447
+3,305
+5% +$19.4K 0.01% 644
2019
Q2
$793K Buy
66,142
+5,107
+8% +$61.2K 0.03% 438
2019
Q1
$736K Buy
61,035
+2,350
+4% +$28.3K 0.03% 427
2018
Q4
$736K Buy
58,685
+10,725
+22% +$135K 0.04% 400
2018
Q3
$712K Buy
47,960
+4,700
+11% +$69.8K 0.03% 427
2018
Q2
$728K Buy
43,260
+13,260
+44% +$223K 0.04% 373
2018
Q1
$687K Buy
30,000
+14,350
+92% +$329K 0.05% 346
2017
Q4
$404K Buy
15,650
+10,650
+213% +$275K 0.03% 406
2017
Q3
$73K Buy
5,000
+2,550
+104% +$37.2K 0.01% 604
2017
Q2
$34K Hold
2,450
﹤0.01% 729
2017
Q1
$41K Buy
+2,450
New +$41K 0.01% 601